Get the Stockscreener App
2.46
1.23%
0.03
Xbiotech Inc Stock (XBIT) Forecast
The Xbiotech Inc (XBIT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $17.41, representing a +607.53% increase from the current price of $2.46. The highest analyst price target is $18.73, and the lowest is $16.08.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XBIT Price Target
Average 13.98
(+468.18% Upside)
Is Xbiotech Inc (XBIT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.73 | Neutral |
| STOCH(9,6) | 68.29 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0146 | Buy |
| ADX(14) | 16.86 | Neutral |
| William %R | -12.50 | Sell |
| CCI(14) | 230.32 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.36
Buy
|
2.3762
Buy
|
| MA20 |
2.3448
Buy
|
2.3567
Buy
|
| MA50 |
2.3455
Buy
|
2.3707
Buy
|
| MA100 |
2.4105
Buy
|
2.4374
Buy
|
| MA200 |
2.6071
Sell
|
2.6576
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, XBIT could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 4 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on XBIT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.73 indicates that XBIT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 68.29 indicates that XBIT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that XBIT is oversold. This suggests that XBIT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.86 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 230.32 indicates that XBIT is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term XBIT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Xbiotech Inc financial reports and earnings history, Xbiotech Inc (XBIT) stock could reach $6.7118 by 2030, $0.7297 by 2040 and $2.6139 by 2050. See the projected annual prices until 2050 of the Xbiotech Inc stock below:
- Xbiotech Inc (XBIT) is expected to reach an average price of $0.8256 in 2035, with a high prediction of $1.6801 and a low estimate of $0.7556. This indicates an $-66.44% rise from the last recorded price of $2.46.
- Xbiotech Inc (XBIT) stock is projected to chart a bullish course in 2040, with an average price target of $0.7847, representing an $-68.10% surge from its current level. The forecast ranges from a conservative $0.7002 to a sky-high $0.7297.
- Our analysts predict Xbiotech Inc (XBIT) to jump -20.18% by 2045, soaring from $1.8544 to an average price of $1.9635, potentially reaching $1.9871. While $1.8544 is the low estimate, the potential upside is significant.
- Xbiotech Inc (XBIT) stock is expected to climb by 2050, reaching an average of $2.2376, a $-9.04% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.6139 and $1.2076, respectively, highlighting the market's uncertainty.
Xbiotech Inc Stock (XBIT) Year by Year Forecast
Xbiotech Inc Stock (XBIT) Price Forecast for 2026
The predicted value for Xbiotech Inc (XBIT) in 2026 is set at an average of $15.28. Estimates vary from a peak of $19.22 to a trough of $11.34, indicating an +521.10% surge from the present price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $18.18 | $16.08 | $18.73 | +638.93% |
| June, 2026 | $15.43 | $14.88 | $18.58 | +527.29% |
| July, 2026 | $15.60 | $14.49 | $16.54 | +533.98% |
| August, 2026 | $15.45 | $15.05 | $16.38 | +528.03% |
| September, 2026 | $16.46 | $13.95 | $16.67 | +569.27% |
| October, 2026 | $14.69 | $13.78 | $16.96 | +497.06% |
| November, 2026 | $14.47 | $13.58 | $15.00 | +488.27% |
| December, 2026 | $11.46 | $11.34 | $14.80 | +365.69% |
Xbiotech Inc Stock (XBIT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Xbiotech Inc (XBIT) is $9.202, with a high forecast of $14.98 and a low forecast of $3.4225. This indicates an +274.06% increase from the last price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $12.55 | $10.71 | $12.67 | +410.15% |
| February, 2027 | $11.18 | $11.14 | $14.98 | +354.60% |
| March, 2027 | $10.06 | $9.2269 | $11.64 | +308.85% |
| April, 2027 | $10.12 | $9.3796 | $10.42 | +311.44% |
| May, 2027 | $8.2551 | $7.8051 | $9.9624 | +235.57% |
| June, 2027 | $7.9397 | $7.6277 | $9.0857 | +222.75% |
| July, 2027 | $7.1733 | $7.0633 | $8.3215 | +191.60% |
| August, 2027 | $6.227 | $6.157 | $7.8052 | +153.13% |
| September, 2027 | $4.1316 | $3.9066 | $7.6379 | +67.95% |
| October, 2027 | $3.6752 | $3.6352 | $4.8043 | +49.40% |
| November, 2027 | $4.3789 | $3.6561 | $5.0361 | +78.00% |
| December, 2027 | $3.6934 | $3.4225 | $4.2698 | +50.14% |
Xbiotech Inc Stock (XBIT) Price Forecast for 2028
In 2028, Xbiotech Inc (XBIT) is projected to reach an average price of $3.4295, with a high projection of $5.2891 and a low estimate of $1.5698. This indicates an +39.41% rise from the last price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.6171 | $2.4571 | $3.8043 | +6.38% |
| February, 2028 | $2.1807 | $2.1107 | $2.913 | -11.35% |
| March, 2028 | $2.0753 | $1.8135 | $2.5125 | -15.64% |
| April, 2028 | $1.7489 | $1.7089 | $2.2786 | -28.91% |
| May, 2028 | $1.6535 | $1.5698 | $2.0408 | -32.78% |
| June, 2028 | $2.7772 | $1.5744 | $3.3772 | +12.89% |
| July, 2028 | $2.4208 | $2.1608 | $3.1681 | -1.59% |
| August, 2028 | $1.9254 | $1.8026 | $2.4017 | -21.73% |
| September, 2028 | $2.199 | $1.7872 | $2.199 | -10.61% |
| October, 2028 | $1.9427 | $1.6418 | $2.3899 | -21.03% |
| November, 2028 | $3.7072 | $1.8086 | $4.5754 | +50.70% |
| December, 2028 | $4.5409 | $3.7081 | $5.2891 | +84.59% |
Xbiotech Inc Stock (XBIT) Price Forecast for 2029
The 2029 price forecast for Xbiotech Inc Stock (XBIT) is $5.3683 on average, with a high prediction of $8.6038 and a low estimate of $2.1328. This represents an +118.22% increase from the previous price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.6354 | $3.4954 | $4.6018 | +47.78% |
| February, 2029 | $4.2691 | $3.4073 | $4.5791 | +73.54% |
| March, 2029 | $3.1627 | $3.0977 | $4.47 | +28.57% |
| April, 2029 | $2.5464 | $2.2155 | $3.2736 | +3.51% |
| May, 2029 | $2.561 | $2.3282 | $3.06 | +4.10% |
| June, 2029 | $2.6046 | $2.1328 | $2.6819 | +5.88% |
| July, 2029 | $2.6283 | $2.3555 | $3.6664 | +6.84% |
| August, 2029 | $3.2228 | $2.5301 | $4.021 | +31.01% |
| September, 2029 | $5.0865 | $3.0638 | $5.8765 | +106.77% |
| October, 2029 | $6.141 | $4.231 | $6.141 | +149.64% |
| November, 2029 | $6.6847 | $5.757 | $8.6038 | +171.74% |
| December, 2029 | $6.54 | $5.68 | $7.3074 | +165.85% |
Xbiotech Inc Stock (XBIT) Price Forecast for 2030
Xbiotech Inc Stock (XBIT) is expected to reach an average price of $13.42 in 2030, with a high forecast of $23.23 and a low forecast of $3.6155. This signifies an +445.70% surge from the last price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.9291 | $3.6155 | $6.7118 | +59.72% |
| February, 2030 | $4.0964 | $3.686 | $4.9146 | +66.52% |
| March, 2030 | $4.1637 | $3.6601 | $4.2901 | +69.26% |
| April, 2030 | $5.111 | $3.6356 | $5.7192 | +107.77% |
| May, 2030 | $7.2052 | $5.1529 | $7.5002 | +192.89% |
| June, 2030 | $6.7375 | $4.9838 | $7.602 | +173.88% |
| July, 2030 | $9.7516 | $6.4193 | $12.08 | +296.41% |
| August, 2030 | $16.65 | $7.4002 | $19.77 | +576.99% |
| September, 2030 | $15.10 | $14.68 | $17.58 | +513.87% |
| October, 2030 | $11.79 | $11.57 | $23.23 | +379.28% |
| November, 2030 | $6.8526 | $6.4976 | $13.73 | +178.56% |
| December, 2030 | $8.0549 | $5.7494 | $8.4349 | +227.44% |
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):